AKOYA BIOSCIENCES, INC.

Profile

Company Names

AKOYA BIOSCIENCES, INC.

Addresses

1505 O-BRIEN DRIVE, SUITE A-1, MENLO PARK, CA 94025

360 POST STREET, SUITE 601, SAN FRANCISCO, CA 94108

Phone Numbers

650-281-0888
415-765-6980

 

Entity Type:

CORPORATION

Industry:

OTHER

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$33,500,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2018-09-26 
$24,500,000.00 
$25,500,000.00 
$1,000,000.00 
Equity 
1
2017-07-12 
$9,000,000.00 
$9,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROB 
 
HART 
EXECUTIVE OFFICER
AQUARO HISTOLOGY, INC.   |  AKOYA BIOSCIENCES, INC.   |  INVISALERT SOLUTIONS, INC.   |  NIMBLE THERAPEUTICS, INC.   |  GRAYHAWK HEALTH, INC.
BRIAN 
 
MCKELLIGON 
EXECUTIVE OFFICER, DIRECTOR
AKOYA BIOSCIENCES, INC.
GARRY 
 
NOLAN 
DIRECTOR
DVS SCIENCES, INC.   |  BINA TECHNOLOGIES INC.   |  AKOYA BIOSCIENCES, INC.
THOMAS 
 
RAFFIN 
DIRECTOR
BIOPROTECTION SYSTEMS CORP   |  LDR HOLDING CORP   |  AQUARO HISTOLOGY, INC.   |  AKOYA BIOSCIENCES, INC.
ROBERT 
 
SHEPLER 
DIRECTOR
VIDACARE CORP   |  LDR HOLDING CORP   |  RARECYTE, INC.   |  AKOYA BIOSCIENCES, INC.
MATTHEW 
 
WINKLER 
DIRECTOR
SECOND GENOME, INC.   |  MIRNA THERAPEUTICS, INC.   |  AKOYA BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-10-02
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2018-09-26 
2017-07-14
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-12 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#